Cytomx Therapeutics Inc Stock
Cytomx Therapeutics Inc Stock
A loss of -2.360% shows a downward development for Cytomx Therapeutics Inc.
The community is currently still undecided about Cytomx Therapeutics Inc with 1 Buy predictions and 1 Sell predictions.
With a target price of 50 € there is potential for a 3082.69% increase which would mean more than doubling the current price of 1.57 € for Cytomx Therapeutics Inc.
Our community identified positive and negative aspects for Cytomx Therapeutics Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Cytomx Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Cytomx Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cytomx Therapeutics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cytomx Therapeutics Inc | -2.360% | -2.905% | 2.546% | -2.179% | 12.536% | -74.702% | - |
Ardelyx Inc. | 3.070% | 1.608% | 5.441% | 102.500% | 9.308% | 7.085% | - |
Evolus Inc | - | 0.000% | 7.477% | 37.725% | 27.072% | 32.948% | - |
Salarius Pharmaceuticals Inc. | - | -3.015% | -6.311% | -66.724% | -30.450% | -98.501% | -99.994% |